Published in Clin Res Hepatol Gastroenterol on July 21, 2011
Incomplete radiofrequency ablation enhances invasiveness and metastasis of residual cancer of hepatocellular carcinoma cell HCCLM3 via activating β-catenin signaling. PLoS One (2014) 1.52
MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma. PLoS One (2012) 1.42
Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer. Oncotarget (2012) 1.12
MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2. J Transl Med (2014) 1.04
Decorin deficiency promotes hepatic carcinogenesis. Matrix Biol (2013) 0.97
γ-Catenin at adherens junctions: mechanism and biologic implications in hepatocellular cancer after β-catenin knockdown. Neoplasia (2013) 0.88
Long non-coding RNA HOTAIR is a marker for hepatocellular carcinoma progression and tumor recurrence. Oncol Lett (2016) 0.87
Pomegranate Bioactive Constituents Suppress Cell Proliferation and Induce Apoptosis in an Experimental Model of Hepatocellular Carcinoma: Role of Wnt/ β -Catenin Signaling Pathway. Evid Based Complement Alternat Med (2013) 0.87
Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone. Cell Cycle (2013) 0.85
MicroRNA-153 promotes Wnt/β-catenin activation in hepatocellular carcinoma through suppression of WWOX. Oncotarget (2015) 0.85
Regulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system. PLoS One (2012) 0.85
Cytoplasmic and/or nuclear expression of β-catenin correlate with poor prognosis and unfavorable clinicopathological factors in hepatocellular carcinoma: a meta-analysis. PLoS One (2014) 0.85
P21-activated kinase 5 plays essential roles in the proliferation and tumorigenicity of human hepatocellular carcinoma. Acta Pharmacol Sin (2013) 0.84
Role of leukocyte cell-derived chemotaxin 2 as a biomarker in hepatocellular carcinoma. PLoS One (2014) 0.83
Targeted therapies in the treatment of advanced hepatocellular carcinoma. Clin Med Insights Oncol (2013) 0.83
Klotho: a tumor suppressor and modulator of the Wnt/β-catenin pathway in human hepatocellular carcinoma. Lab Invest (2015) 0.82
Pygopus-2 promotes invasion and metastasis of hepatic carcinoma cell by decreasing E-cadherin expression. Oncotarget (2015) 0.81
Androgen receptor in hepatocarcinogenesis: Recent developments and perspectives. Oncol Lett (2015) 0.79
Suppression of Hepatocellular Carcinoma by Inhibition of Overexpressed Ornithine Aminotransferase. ACS Med Chem Lett (2015) 0.78
Adeno-associated virus-mediated microRNA delivery and therapeutics. Semin Liver Dis (2015) 0.78
CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment. Oncotarget (2016) 0.77
β‑catenin signaling pathway regulates cisplatin resistance in lung adenocarcinoma cells by upregulating Bcl‑xl. Mol Med Rep (2016) 0.77
A review on the diagnosis and treatment of hepatocellular carcinoma with a focus on the role of Wnts and the dickkopf family of Wnt inhibitors. J Hepatocell Carcinoma (2014) 0.76
Immunobiology of hepatocarcinogenesis: Ways to go or almost there? World J Gastrointest Pathophysiol (2016) 0.76
Interaction of key pathways in sorafenib-treated hepatocellular carcinoma based on a PCR-array. Int J Clin Exp Pathol (2015) 0.75
Blocking Wnt Secretion Reduces Growth of Hepatocellular Carcinoma Cell Lines Mostly Independent of β-Catenin Signaling. Neoplasia (2016) 0.75
HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway. Cancer Sci (2016) 0.75
Wnt-/-β-catenin pathway signaling in human hepatocellular carcinoma. World J Hepatol (2015) 0.75
Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma. J Gastroenterol (2016) 0.75
Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine. Development (2005) 2.56
Apc tumor suppressor gene is the "zonation-keeper" of mouse liver. Dev Cell (2006) 2.45
New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene (2002) 2.23
Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res (2005) 1.92
Functional intestinal stem cells after Paneth cell ablation induced by the loss of transcription factor Math1 (Atoh1). Proc Natl Acad Sci U S A (2012) 1.83
Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers. Lab Invest (2004) 1.82
T-cell factor 4 and β-catenin chromatin occupancies pattern zonal liver metabolism in mice. Hepatology (2014) 1.65
Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer. Cancer Res (2007) 1.56
Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res (2006) 1.44
A genetic study of the role of the Wnt/beta-catenin signalling in Paneth cell differentiation. Dev Biol (2008) 1.42
EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma. J Hepatol (2009) 1.33
Complex interplay between β-catenin signalling and Notch effectors in intestinal tumorigenesis. Gut (2011) 1.33
Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate. Hepatology (2008) 1.31
Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice. J Clin Invest (2012) 1.24
18F-FDG PET/CT imaging for an early assessment of response to sunitinib in metastatic renal carcinoma: preliminary study. Cancer Biother Radiopharm (2009) 1.22
Proteomic analysis of beta-catenin activation in mouse liver by DIGE analysis identifies glucose metabolism as a new target of the Wnt pathway. Proteomics (2009) 1.14
Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver. Hepatology (2004) 1.12
Transcription dynamics in a physiological process: β-catenin signaling directs liver metabolic zonation. Int J Biochem Cell Biol (2009) 1.10
Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology. Future Oncol (2008) 1.06
Induction of immunosuppressive molecules and regulatory T cells counteracts the antitumor effect of interleukin-12-based gene therapy in a transgenic mouse model of liver cancer. J Hepatol (2007) 1.06
Molecular determinants of liver zonation. Prog Mol Biol Transl Sci (2010) 1.05
The transforming growth factor-α and cyclin D1 genes are direct targets of β-catenin signaling in hepatocyte proliferation. J Hepatol (2010) 1.05
Gene expression profiling provides insights into the pathways involved in solid pseudopapillary neoplasm of the pancreas. J Pathol (2009) 0.96
TWIST1 a new determinant of epithelial to mesenchymal transition in EGFR mutated lung adenocarcinoma. PLoS One (2012) 0.96
Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways. Carcinogenesis (2012) 0.95
Overexpression of human beta TrCP1 deleted of its F box induces tumorigenesis in transgenic mice. Oncogene (2005) 0.92
Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers. Gastroenterology (2009) 0.90
Overexpression of ornithine aminotransferase: consequences on amino acid homeostasis. Br J Nutr (2008) 0.85
Parathyroid scintigraphy findings in chronic kidney disease patients with recurrent hyperparathyroidism. Eur J Nucl Med Mol Imaging (2009) 0.85
The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis. J Hepatol (2012) 0.84
c-myc-induced hepatocarcinogenesis in the absence of IGF-I receptor. Int J Cancer (2005) 0.83
Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice. PLoS One (2010) 0.82
The tumor suppressor Apc controls planar cell polarities central to gut homeostasis. J Cell Biol (2012) 0.81
Methylation profile as a new tool for classification of hepatocellular carcinoma. J Hepatol (2010) 0.81
Slow dynamic lymphoscintigraphy is not a reliable predictor of sentinel-node negativity in cutaneous melanoma. Cancer Biother Radiopharm (2008) 0.80
PKM2: a new player in the β-catenin game. Future Oncol (2012) 0.79
[Wnt/beta-catenin pathway and liver metabolic zonation: a new player for an old concept]. Med Sci (Paris) (2006) 0.78
[Activating a beta-catenin signal in the liver is oncogenic]. Med Sci (Paris) (2005) 0.75
[Sirtuin 1, hepatic steatosis and liver cancer]. Med Sci (Paris) (2012) 0.75
[Wnt and gastrointestinal stem cells: dangerous connections]. Med Sci (Paris) (2006) 0.75
Monte Carlo simulation of electron dose from (131)I-targeted tumor cells within a heterogeneous tumor. Cancer Biother Radiopharm (2011) 0.75
[NKT cells in the liver environment interact with Wnt/β-catenin and promote the emergence of liver carcinoma]. Med Sci (Paris) (2012) 0.75